| scholarly article | Q13442814 |
| P2093 | author name string | Xuejun Wang | |
| Ming Fang | |||
| Xinming Li | |||
| Yanfei Li | |||
| Yingbiao Wu | |||
| Zhongping Ning | |||
| P2860 | cites work | STIM1, an essential and conserved component of store-operated Ca2+ channel function | Q24678317 |
| Biologic plausibility, cellular effects, and molecular mechanisms of eicosapentaenoic acid (EPA) in atherosclerosis | Q26801002 | ||
| Nanoscale patterning of STIM1 and Orai1 during store-operated Ca2+ entry | Q27318612 | ||
| miR-185 plays an anti-hypertrophic role in the heart via multiple targets in the calcium-signaling pathways | Q28544014 | ||
| Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs | Q34214431 | ||
| Reduction of Store-Operated Ca(2+) Entry Correlates with Endothelial Progenitor Cell Dysfunction in Atherosclerotic Mice | Q35844381 | ||
| Cross-talk between macrophages and smooth muscle cells impairs collagen and metalloprotease synthesis and promotes angiogenesis | Q35984304 | ||
| MiR-185 acts as a tumor suppressor by targeting AKT1 in non-small cell lung cancer cells | Q36262119 | ||
| VEGF in the crosstalk between human adipocytes and smooth muscle cells: depot-specific release from visceral and perivascular adipose tissue | Q37044529 | ||
| Evidence for STIM1- and Orai1-dependent store-operated calcium influx through ICRAC in vascular smooth muscle cells: role in proliferation and migration | Q37280839 | ||
| miRNAs: Key Players in Neurodegenerative Disorders and Epilepsy | Q37535111 | ||
| Down-regulation of hsa-miR-148b inhibits vascular smooth muscle cells proliferation and migration by directly targeting HSP90 in atherosclerosis | Q37685274 | ||
| Thrombosis and acute coronary syndrome | Q37979021 | ||
| Psychological interventions for coronary heart disease: cochrane systematic review and meta-analysis. | Q38062403 | ||
| Pathogenesis and treatment of atherosclerosis in lupus | Q38230699 | ||
| The potential of miRNAs as biomarkers for multiple myeloma | Q38237446 | ||
| Smooth muscle cell phenotypic switch: implications for foam cell formation | Q38238775 | ||
| Thrombosis formation on atherosclerotic lesions and plaque rupture | Q38243253 | ||
| miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart | Q38591803 | ||
| RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2. | Q38738479 | ||
| MicroRNA-185 is a novel tumor suppressor by negatively modulating the Wnt/β-catenin pathway in human colorectal cancer | Q38756063 | ||
| Elevated Orai1 and STIM1 expressions upregulate MACC1 expression to promote tumor cell proliferation, metabolism, migration, and invasion in human gastric cancer | Q38757267 | ||
| MicroRNA-185 inhibits angiogenesis in human microvascular endothelial cells through targeting stromal interaction molecule 1. | Q38809740 | ||
| MiR-185 is involved in human breast carcinogenesis by targeting Vegfa | Q38935102 | ||
| MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine | Q39210882 | ||
| Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events | Q39977385 | ||
| microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator | Q40367401 | ||
| Evidence that Orai1 does not contribute to store-operated TRPC1 channels in vascular smooth muscle cells. | Q41378888 | ||
| Establishment of a rat model with diet-induced coronary atherosclerosis | Q41834646 | ||
| Urotensin-II promotes vascular smooth muscle cell proliferation through store-operated calcium entry and EGFR transactivation | Q41872921 | ||
| Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL | Q42084567 | ||
| Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma | Q42377198 | ||
| Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation | Q44618122 | ||
| Lectin-like oxidized low-density lipoprotein receptor-1 promotes endothelial dysfunction in LDL receptor knockout background | Q46269905 | ||
| Small molecule-mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation and neointima formation after balloon injury. | Q47100278 | ||
| miRNA-22 is a Novel Mediator of Vascular Smooth Muscle Cell Phenotypic Modulation and Neointima Formation | Q47287722 | ||
| Therapeutic impacts of microRNAs in breast cancer by their roles in regulating processes involved in this disease | Q47701015 | ||
| MiR-362-3p inhibits the proliferation and migration of vascular smooth muscle cells in atherosclerosis by targeting ADAMTS1. | Q47825786 | ||
| MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer | Q49335779 | ||
| miRNA-185 serves as a prognostic factor and suppresses migration and invasion through Wnt1 in colon cancer | Q49898195 | ||
| AIM2 regulates vascular smooth muscle cell migration in atherosclerosis. | Q49968331 | ||
| A study on blocking store-operated Ca2+ entry in pulmonary arterial smooth muscle cells with xyloketals from marine fungi | Q50027592 | ||
| Oxidized low-density lipoprotein in inflammation-driven thrombosis | Q50117736 | ||
| Chronic intermittent mental stress promotes atherosclerotic plaque vulnerability, myocardial infarction and sudden death in mice. | Q50576198 | ||
| Circulating microRNAs as Novel Biomarkers for Atherosclerosis. | Q52562931 | ||
| Oxidized LDL phagocytosis during foam cell formation in atherosclerotic plaques relies on a PLD2-CD36 functional interdependence. | Q52587771 | ||
| MicroRNAs as Potential Mediators for Cigarette Smoking Induced Atherosclerosis. | Q52593752 | ||
| Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Rela | Q53491842 | ||
| High pH-Sensitive Store-Operated Ca2+ Entry Mediated by Ca2+ Release-Activated Ca2+ Channels in Rat Odontoblasts. | Q54210688 | ||
| 1,25-Dihydroxyvitamin D3 stimulates vascular smooth muscle cell proliferation through a VEGF-mediated pathway. | Q54612212 | ||
| Knockdown of stromal interaction molecule 1 inhibits proliferation of colorectal cancer cells by inducing apoptosis. | Q55180378 | ||
| Dan-Lou Prescription Inhibits Foam Cell Formation Induced by ox-LDL via the TLR4/NF-κB and PPARγ Signaling Pathways. | Q55246298 | ||
| A sialoadenectomy is associated with an increased risk of coronary heart disease: A three-year follow-up study. | Q55325723 | ||
| Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling | Q58079236 | ||
| Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture | Q60924495 | ||
| Role of MicroRNAs in Renal Parenchymal Diseases-A New Dimension. | Q64924544 | ||
| Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture | Q72034135 | ||
| Simvastatin increases Prolyl-4-Hydroxylase α1 expression in atherosclerotic plaque and ox-LDL-stimulated human aortic smooth muscle cells via p38 MAPK and ERK1/2 signaling | Q86066160 | ||
| Human sLZIP promotes atherosclerosis via MMP-9 transcription and vascular smooth muscle cell migration | Q87472943 | ||
| Nesfatin-1 promotes VSMC migration and neointimal hyperplasia by upregulating matrix metalloproteinases and downregulating PPARγ | Q88234157 | ||
| Microrna-145 accelerates the inflammatory reaction through activation of NF-κB signaling in atherosclerosis cells and mice | Q88517564 | ||
| Retraction notice to "MicroRNA-21 suppresses ox-LDL-induced human aortic endothelial cells injuries in atherosclerosis through enhancement of autophagic flux: Involvement in promotion of lysosomal function" [Experimental Cell Research 359 Issue 2 (2 | Q89029745 | ||
| P433 | issue | 6-7 | |
| P1104 | number of pages | 14 | |
| P304 | page(s) | 682-695 | |
| P577 | publication date | 2019-03-20 | |
| P1433 | published in | Cell Cycle | Q1254166 |
| P1476 | title | miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1 | |
| P478 | volume | 18 |
| Q98779240 | 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) and Polychlorinated Biphenyl Coexposure Alters the Expression Profile of MicroRNAs in the Liver Associated with Atherosclerosis |
| Q92099913 | Effect of microRNA-144-5p on the proliferation, invasion and migration of human umbilical vein endothelial cells by targeting SMAD1 |
| Q92941380 | Very Low-Density Lipoproteins of Metabolic Syndrome Modulates STIM1, Suppresses Store-Operated Calcium Entry, and Deranges Myofilament Proteins in Atrial Myocytes |
| Q94517885 | miR-185 inhibits prostate cancer angiogenesis induced by the nodal/ALK4 pathway |
Search more.